Temazepam Capsule
Product Images NDC 70518-0647

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temazepam (NDC 70518-0647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Temazepam 15 mg oral capsules, containing 30 capsules per container. The label features the RemedyRepack Inc. logo and indicates the product is Schedule IV (C-IV). Manufacturer is Ascend Labs, LLC, Montvale, NJ. The label includes barcode, NDC 70518-0647-00, and cautions to keep medication out of reach of children.*

FDA Label Image

Temazepam Header

Temazepam Capsules, USP 15 mg oral capsules. The label displays the proprietary and generic name 'temazepam' along with a symbol indicating Schedule IV controlled substance classification. The product is from RemedyRepack Inc.*

FDA Label Image

Temazepam Str

Chemical structure diagram of temazepam, showing its molecular framework including a chlorinated benzene ring, a diazepine ring with a methyl group, and a carboxylic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.